Genetic mouse models of neurodegenerative disorders can provide valuable insight into the pathogenesis of the corresponding human condition, and can serve to address specific hypotheses about the biology of the relevant gene product in health and disease. Investigations into genes that cause inherited forms of Parkinson's disease (PD), the mechanisms involved in their cellular and molecular biology, as well as the downstream pathways that they trigger shed considerable light on our understanding the fundamental determinants of life and death in dopaminergic neurons. DJ-1 is one of five genes identified thus far to be definitely linked to inherited PD. The two original mutations identified in the DJ-1 locus in affected pedigrees are transmitted recessively suggesting loss of function. Although considerable knowledge about the anti- oxidant properties of DJ-1 has been generated, and its diverse functions in other systems have been studied, its role in the biology of dopaminergic neurons has been addressed in limited studies and remains poorly understood. Therefore, how DJ-1 protects cells and how its absence or point mutations result in dopamine neuronal death remain largely unanswered questions. To date, the cytoprotective activity of DJ-1 against oxidant damage has been attributed largely to its reactive oxygen species (ROS) quenching ability. However, our findings indicate that the ROS quenching potential of DJ-1 is weak compared to its robust cell preserving activity. Rather, our data point to an alternative mechanism for the cytoprotective function of DJ-1 which appears to have a critical role in inhibiting a specific kinase-mediated cell death-signaling pathway. The end result is protection against insults that activate this pathway, including oxidant damage. The pathogenic relevance of this proposed scheme in PD is strengthened by failure of a PD-causing DJ-1 mutant at each step of this pathway. This application proposes to investigate the in vivo validity of this hypothesis using a novel genetic mouse model. This proposal also addresses the relatively selective vulnerability of dopaminergic neurons to DJ-1 deletion despite its ubiquitous expression. For lay public: The goal of this project is to understand how mutations in DJ-1, a gene responsible for some forms of Parkinson's disease, cause degeneration of dopamine producing brain cells. Elucidating the steps in this process can help develop treatments that could block its progression. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21NS053517-01A1
Application #
7140768
Study Section
Special Emphasis Panel (ZRG1-NDBG-A (09))
Program Officer
Murphy, Diane
Project Start
2006-07-01
Project End
2008-06-30
Budget Start
2006-07-01
Budget End
2007-06-30
Support Year
1
Fiscal Year
2006
Total Cost
$174,938
Indirect Cost
Name
University of Medicine & Dentistry of NJ
Department
Neurology
Type
Schools of Medicine
DUNS #
617022384
City
Piscataway
State
NJ
Country
United States
Zip Code
08854
Oh, Stephanie E; Mouradian, M Maral (2017) Regulation of Signal Transduction by DJ-1. Adv Exp Med Biol 1037:97-131
Lee, Kang-Woo; Woo, Jong-Min; Im, Joo-Young et al. (2015) Apoptosis signal-regulating kinase 1 modulates the phenotype of ?-synuclein transgenic mice. Neurobiol Aging 36:519-26
Dias, Vera; Junn, Eunsung; Mouradian, M Maral (2013) The role of oxidative stress in Parkinson's disease. J Parkinsons Dis 3:461-91
Lee, Kang-Woo; Zhao, Xin; Im, Joo-Young et al. (2012) Apoptosis signal-regulating kinase 1 mediates MPTP toxicity and regulates glial activation. PLoS One 7:e29935
Braithwaite, Steven P; Stock, Jeffry B; Mouradian, M Maral (2012) ?-Synuclein phosphorylation as a therapeutic target in Parkinson's disease. Rev Neurosci 23:191-8
Im, Joo-Young; Lee, Kang-Woo; Woo, Jong-Min et al. (2012) DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway. Hum Mol Genet 21:3013-24
Grosso, Hilary; Mouradian, M Maral (2012) Transglutaminase 2: biology, relevance to neurodegenerative diseases and therapeutic implications. Pharmacol Ther 133:392-410
Junn, Eunsung; Mouradian, M Maral (2012) MicroRNAs in neurodegenerative diseases and their therapeutic potential. Pharmacol Ther 133:142-50
Im, Joo-Young; Lee, Kang-Woo; Junn, Eunsung et al. (2010) DJ-1 protects against oxidative damage by regulating the thioredoxin/ASK1 complex. Neurosci Res 67:203-8
Junn, Eunsung; Jang, Won Hee; Zhao, Xin et al. (2009) Mitochondrial localization of DJ-1 leads to enhanced neuroprotection. J Neurosci Res 87:123-9